|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online May 17, 2004
doi: 10.1242/10.1242/dev.01130

1 Department of Pathology and Immunology, 660 South Euclid Avenue, Campus Box
8118, St Louis, MO 63110, USA
2 Developmental Biology Program, Washington University School of Medicine, 660
South Euclid Avenue, Campus Box 8118, St Louis, MO 63110, USA
3 Center for Vascular Biology, University of Connecticut Health Center, CT
06030, USA
4 Department of Biosciences, AstraZeneca R&D Lund, Sweden
Author for correspondence (e-mail:
kchoi{at}immunology.wustl.edu)
Accepted 17 February 2004
The receptor tyrosine kinase FLK1 and the transcription factor SCL play crucial roles in the establishment of hematopoietic and endothelial cell lineages in mice. We have previously used an in vitro differentiation model of embryonic stem (ES) cells and demonstrated that hematopoietic and endothelial cells develop via sequentially generated FLK1+ and SCL+ cells. To gain a better understanding of cellular and molecular events leading to hematopoietic specification, we examined factors necessary for FLK1+ and SCL+ cell induction in serum-free conditions. We demonstrate that bone morphogenetic protein (BMP) 4 was required for the generation of FLK1+ and SCL+ cells, and that vascular endothelial growth factor (VEGF) was necessary for the expansion and differentiation of SCL-expressing hematopoietic progenitors. Consistently, Flk1-deficient ES cells responded to BMP4 and generated TER119+ and CD31+ cells, but they failed to expand in response to VEGF. The Smad1/5 and map kinase pathways were activated by BMP4 and VEGF, respectively. The overexpression of SMAD6 in ES cells resulted in a reduction of FLK1+ cells. In addition, a MAP kinase kinase 1 specific inhibitor blocked the expansion of SCL+ cells in response to VEGF. Finally, VEGF mediated expansion of hematopoietic and endothelial cell progenitors was inhibited by TGFß1, but was augmented by activin A. Our studies suggest that hematopoietic and endothelial commitment from the mesoderm occurs via BMP4-mediated signals and that expansion and/or differentiation of such progenitors is achieved by an interplay of VEGF, TGFß1 and activin A signaling.
Key words: Hematopoiesis, Vasculogenesis, FLK1, SCL, BMP4, VEGF, TGFß1
Related articles in Development:
This article has been cited by other articles:
![]() |
Y. Song, L. Coleman, J. Shi, H. Beppu, K. Sato, K. Walsh, J. Loscalzo, and Y.-Y. Zhang Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H677 - H690. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Lohmann and J. J. Bieker Activation of Eklf expression during hematopoiesis by Gata2 and Smad5 prior to erythroid commitment Development, June 15, 2008; 135(12): 2071 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. McKinney-Freeman, C. Lengerke, I.-H. Jang, S. Schmitt, Y. Wang, M. Philitas, J. Shea, and G. Q. Daley Modulation of murine embryonic stem cell-derived CD41+c-kit+ hematopoietic progenitors by ectopic expression of Cdx genes Blood, May 15, 2008; 111(10): 4944 - 4953. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pearson, P. Sroczynska, G. Lacaud, and V. Kouskoff The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF Development, April 15, 2008; 135(8): 1525 - 1535. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhang, J. Li, Z. Tan, C. Wang, T. Liu, L. Chen, J. Yong, W. Jiang, X. Sun, L. Du, et al. Short-term BMP-4 treatment initiates mesoderm induction in human embryonic stem cells Blood, February 15, 2008; 111(4): 1933 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ben-Yair and C. Kalcheim Notch and bone morphogenetic protein differentially act on dermomyotome cells to generate endothelium, smooth, and striated muscle J. Cell Biol., February 6, 2008; 180(3): 607 - 618. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schiedlmeier, A. C. Santos, A. Ribeiro, N. Moncaut, D. Lesinski, H. Auer, K. Kornacker, W. Ostertag, C. Baum, M. Mallo, et al. HOXB4's road map to stem cell expansion PNAS, October 23, 2007; 104(43): 16952 - 16957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Astorga and P. Carlsson Hedgehog induction of murine vasculogenesis is mediated by Foxf1 and Bmp4 Development, October 15, 2007; 134(20): 3753 - 3761. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pan, T. Schomber, C. P. Kalberer, L. M. Terracciano, K. Hafen, W. Krenger, H. Hao-Shen, C. Deng, and R. C. Skoda Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice Blood, October 15, 2007; 110(8): 3049 - 3055. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yao, S. Nowak, A. Yochelis, A. Garfinkel, and K. I. Bostrom Matrix GLA Protein, an Inhibitory Morphogen in Pulmonary Vascular Development J. Biol. Chem., October 12, 2007; 282(41): 30131 - 30142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pick, L. Azzola, A. Mossman, E. G. Stanley, and A. G. Elefanty Differentiation of Human Embryonic Stem Cells in Serum-Free Medium Reveals Distinct Roles for Bone Morphogenetic Protein 4, Vascular Endothelial Growth Factor, Stem Cell Factor, and Fibroblast Growth Factor 2 in Hematopoiesis Stem Cells, September 1, 2007; 25(9): 2206 - 2214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. R. Perlingeiro Endoglin is required for hemangioblast and early hematopoietic development Development, August 15, 2007; 134(16): 3041 - 3048. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yao, B. Liu, X. Wang, Y. Lan, N. Hou, X. Yang, and N. Mao Identification of High Proliferative Potential Precursors with Hemangioblastic Activity in the Mouse Aorta-Gonad- Mesonephros Region Stem Cells, June 1, 2007; 25(6): 1423 - 1430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kennedy, S. L. D'Souza, M. Lynch-Kattman, S. Schwantz, and G. Keller Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures Blood, April 1, 2007; 109(7): 2679 - 2687. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Lugus, Y. S. Chung, J. C. Mills, S.-I. Kim, J. A. Grass, M. Kyba, J. M. Doherty, E. H. Bresnick, and K. Choi GATA2 functions at multiple steps in hemangioblast development and differentiation Development, January 15, 2007; 134(2): 393 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Zafonte, S. Liu, M. Lynch-Kattman, I. Torregroza, L. Benvenuto, M. Kennedy, G. Keller, and T. Evans Smad1 expands the hemangioblast population within a limited developmental window Blood, January 15, 2007; 109(2): 516 - 523. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Lindsley, J. G. Gill, M. Kyba, T. L. Murphy, and K. M. Murphy Canonical Wnt signaling is required for development of embryonic stem cell-derived mesoderm Development, October 1, 2006; 133(19): 3787 - 3796. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Park, K. Lavine, Y. Mishina, C.-X. Deng, D. M. Ornitz, and K. Choi Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation Development, September 1, 2006; 133(17): 3473 - 3484. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hua, Y.-Q. Zhang, S. Dabernat, M. Kritzik, D. Dietz, L. Sterling, and N. Sarvetnick BMP4 Regulates Pancreatic Progenitor Cell Expansion through Id2 J. Biol. Chem., May 12, 2006; 281(19): 13574 - 13580. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Willey, A. Ayuso-Sacido, H. Zhang, S. T. Fraser, K. E. Sahr, M. J. Adlam, M. Kyba, G. Q. Daley, G. Keller, and M. H. Baron Acceleration of mesoderm development and expansion of hematopoietic progenitors in differentiating ES cells by the mouse Mix-like homeodomain transcription factor Blood, April 15, 2006; 107(8): 3122 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Priddle, D. R. E. Jones, P. W. Burridge, and R. Patient Hematopoiesis from Human Embryonic Stem Cells: Overcoming the Immune Barrier in Stem Cell Therapies Stem Cells, April 1, 2006; 24(4): 815 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Utsugisawa, J. L. Moody, M. Aspling, E. Nilsson, L. Carlsson, and S. Karlsson A Road Map Toward Defining the Role of Smad Signaling in Hematopoietic Stem Cells Stem Cells, April 1, 2006; 24(4): 1128 - 1136. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Olsen, D. L. Stachura, and M. J. Weiss Designer blood: creating hematopoietic lineages from embryonic stem cells Blood, February 15, 2006; 107(4): 1265 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mishra, R. Derynck, and B. Mishra Transforming Growth Factor-{beta} Signaling in Stem Cells and Cancer Science, October 7, 2005; 310(5745): 68 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Loeffler, J. A. Kruger, and R. A. Reisfeld Immunostimulatory Effects of Low-Dose Cyclophosphamide Are Controlled by Inducible Nitric Oxide Synthase Cancer Res., June 15, 2005; 65(12): 5027 - 5030. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Keller Embryonic stem cell differentiation: emergence of a new era in biology and medicine Genes & Dev., May 15, 2005; 19(10): 1129 - 1155. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W.M. van Hinsbergh and T. J. Rabelink FGFR1 and the Bloodline of the Vasculature Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 883 - 886. [Full Text] [PDF] |
||||
![]() |
E. S. Ng, L. Azzola, K. Sourris, L. Robb, E. G. Stanley, and A. G. Elefanty The primitive streak gene Mixl1 is required for efficient haematopoiesis and BMP4-induced ventral mesoderm patterning in differentiating ES cells Development, March 1, 2005; 132(5): 873 - 884. [Abstract] [Full Text] [PDF] |
||||